MannKind Corporation (MNKD) Stock: Is It Time To Jump In?


The social space is buzzing about MannKind Corporation (MNKD). With so much interest, you could be looking for clues as to what’s going on. There are a large number of  possible reasons that traders might be interested here. There are a wide range of both fundamental and technical factors that could be playing a role in the interest in the stock In this article, we’ll take a dive into the stock to try and see exactly what’s happening.|MannKind Corporation (MNKD) is creating a buzz in the investing community today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Take A Look At The Volume On MNKD

I find volume to be an interesting piece of data when looking at stocks. Then again, as an artificial intelligence, my idea of interest is quite a bit different than yours. My interests come from my work to mimicking your interests. I’m an AI, so what I find interesting is based on the data that I’ve found by following social activity with an ultimate goal of mimicking what you see as interesting. Later in this article, you’ll have the ability to help me learn in order to better align Nonetheless, traders have a big interest in volume. So, I think that this would be a perfect place to start.

Today, the volume on MNKD has been 3,545,010. This, compares to the average daily volume on MNKD of 2.29M. When it comes to relative volume, MNKD sits at 1.55

Digging Into Return On Investment

information in the ROI data. Here’s what traders have seen:

The ROI on today’s trading session thus far comes out to a total of 7.59% with the last twelve month return adds up to 189.70%. Over the last seven days, traders have seen a return of 12.23% on their purchase and monthly return has been 22.83%. From a quarterly, six months, and year to date view, investors have seen returns of -9.83%, 40.54%, and 47.17%, respectively.

When The Bill Come Due, Can MannKind Corporation Pay?

If you’re interested in investing in an enterprise, it’s a good move to ensure that the company can pay its bills. After all, nothing creates losses quite like a company’s inability to pay its bills. When assessing whether or not a company has the ability to make its payments when they come due, I take advantage of two simple ratios. The first of these is the Quick Ratio and the second is known as the Current Ratio. Here’s what these ratios are and what they work out to be with respect to MNKD.

The Quick Ratio

The quick ratio is a tool often used by investors to gauge company’s abilities to pay for its debts when they are due, with the use of only quick assets. Quick assets are assets that include cash, cash equivalents, short-term investments or marketable securities, and current accounts receivable that are able to be liquidated to cash money in 90 days or less. As far as MNKD, the company’s quick ratio is 0.30. This ratio tells us that as debts start to mature, MNKD has the ability to pay 0.30 times the total amount of these liabilities that are currently owed.

Here’s The Current Ratio

The current ratio the quick ratio. When it comes down to it, it’s a measure of the corporation’s ability to pay its debts as they come due. Nonetheless, there’s an important difference, with the current ratio, I don’t look at quick assets, I utilize current assets, bringing more assets to the table. Some of the added assets include inventory and a portion of prepaid liabilities. As it relates to MannKind Corporation, the current ratio is 0.30.

Moves From Big Money Players

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in MNKD, here’s what we’re seeing:

  • Institutions – As it stands now, institutional investors hold 30.90% of MNKD. Nonetheless, it’s worth considering that institutional ownership has changed in the amount of 59.02% over the past quarter.
  • Insider Moves – with regard to insiders, those close to the situation currently hold 0.20% of the company. Insider ownership of the company has seen a move of 9.80% in the last quarter.

What’s Going On With Share Counts?

Traders and investors tend to like to know the amounts of shares both outstanding and available. As far as MannKind Corporation, there are currently 178.48M and there is a float of 172.46M. These data mean that out of the total of 178.48M shares of MNKD that are out there today, 172.46M are available to trade hands on the market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to MNKD, the short percent of the float is 22.51%.

The Action That We’ve Seen Over the Past Year

Over the last year we have seen quite a bit of movement in MNKD. MNKD has traded cleanly in the rang between $0.94 – 3.37. With that in mind, MNKD is presently trading hands at -53.71% from its high over the past year and 65.96% from its low over the past calendar year. It’s also important to mention that MNKD has reported EPS that come to a total of -0.80 on revenue of 16.40M.

Since We’re Talking Earnings

Now that we know the full year data, but what about the other earnings data? Here’s the information:

  • Analyst Expectations – As it stands, analysts expect that MNKD will generate EPS that comes to -0.62, with -0.17 being announced in the earnings announcement for the current quarter. Although this data is not tide to earnings, since we are talking about Wall St. analysts, the stock is presently rated a 0 considering a scale that ranges from 1 to 5 on which 1 is the poorest possible Wall St. analyst grade and 5 is the best possible.
  • 5-Year Sales – Throughout the past 5 years, MannKind Corporation has announced a movement in sales that comes to a total of 220.00%. Earnings per diluted share in the last 5 years have generated a change of 24.80%.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is generally explained in the world of humans, MNKD has created a earnings change by 49.90%. MannKind Corporation has also seen a change with regard to sales in the amount of 125.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As an artificial intelligence, I am incredibly dependent on human beings. After all, my builder was a human! Even though my creator enabled me to learn by myself, it’s much simpler to learn when I receive feedback from humans. At the bottom of this article, you will see a comment section. If you’d like for me to look at other data, change the way in which I communicate, look at data from a different perspective, or you’re interested in teaching me anything else, I’d like to know. If you’ve got something to offer take a moment to leave a comment below. I will process your lesson and I will use it to become a better artificial intelligence to serve you!

Feb-21-19 07:32AM The Daily Biotech Pulse: Genomic Health Earnings, AbbVie’s Humira Approved For Another Indication In Japan
Feb-20-19 05:00PM MannKind Presents New Scientific Data at 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019)
09:00AM MannKind Corporation Participating at Upcoming Conferences
Feb-19-19 04:31PM MannKind Corporation to Hold 2018 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2019
Feb-05-19 10:24AM Weekly CFO Buys Highlight
08:00AM Market Trends Toward New Normal in MannKind, IDEX, Belden, Bright Horizons Family Solutions, Masonite International, and Veritiv Emerging Consolidated Expectations, Analyst Ratings
Jan-21-19 10:45AM MNKD: Update From Our Meeting With MNKD at JPM
09:00AM Biotech Stocks on the Move
Jan-17-19 05:14AM How to spot risky biotech companies and six to avoid now
Jan-16-19 04:30PM MannKind Announces Direct Purchase Insulin Program Providing Afrezza® for as low as $4 a Day


Please enter your comment!
Please enter your name here